319 related articles for article (PubMed ID: 11737582)
41. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
[TBL] [Abstract][Full Text] [Related]
42. Hereditary disorders of renal phosphate wasting.
Alizadeh Naderi AS; Reilly RF
Nat Rev Nephrol; 2010 Nov; 6(11):657-65. PubMed ID: 20924400
[TBL] [Abstract][Full Text] [Related]
43. Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production.
Saito H; Kusano K; Kinosaki M; Ito H; Hirata M; Segawa H; Miyamoto K; Fukushima N
J Biol Chem; 2003 Jan; 278(4):2206-11. PubMed ID: 12419819
[TBL] [Abstract][Full Text] [Related]
44. Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood.
Seton M; Jüppner H
Bone; 2013 Feb; 52(2):640-3. PubMed ID: 23174215
[TBL] [Abstract][Full Text] [Related]
45. Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait.
Goji K; Ozaki K; Sadewa AH; Nishio H; Matsuo M
J Clin Endocrinol Metab; 2006 Feb; 91(2):365-70. PubMed ID: 16303832
[TBL] [Abstract][Full Text] [Related]
46. Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets.
Kapelari K; Köhle J; Kotzot D; Högler W
J Clin Endocrinol Metab; 2015 Sep; 100(9):3388-92. PubMed ID: 26186302
[TBL] [Abstract][Full Text] [Related]
47. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.
Riminucci M; Collins MT; Fedarko NS; Cherman N; Corsi A; White KE; Waguespack S; Gupta A; Hannon T; Econs MJ; Bianco P; Gehron Robey P
J Clin Invest; 2003 Sep; 112(5):683-92. PubMed ID: 12952917
[TBL] [Abstract][Full Text] [Related]
48. Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification.
Rafaelsen SH; Raeder H; Fagerheim AK; Knappskog P; Carpenter TO; Johansson S; Bjerknes R
J Bone Miner Res; 2013 Jun; 28(6):1378-85. PubMed ID: 23325605
[TBL] [Abstract][Full Text] [Related]
49. Novel regulators of phosphate homeostasis and bone metabolism.
Jüppner H
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S3-22. PubMed ID: 17976082
[TBL] [Abstract][Full Text] [Related]
50. Post-translational modification of Fibroblast Growth Factor 23.
Fukumoto S
Ther Apher Dial; 2005 Aug; 9(4):319-22. PubMed ID: 16076374
[TBL] [Abstract][Full Text] [Related]
51. [Autosomal dominant hypophosphatemic rickets/osteomalacia].
Tanaka H
Nihon Rinsho; 2005 Oct; 63 Suppl 10():529-33. PubMed ID: 16279695
[No Abstract] [Full Text] [Related]
52. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna.
Ward LM; Rauch F; White KE; Filler G; Matzinger MA; Letts M; Travers R; Econs MJ; Glorieux FH
Bone; 2004 May; 34(5):905-11. PubMed ID: 15121023
[TBL] [Abstract][Full Text] [Related]
53. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.
Larsson T; Yu X; Davis SI; Draman MS; Mooney SD; Cullen MJ; White KE
J Clin Endocrinol Metab; 2005 Apr; 90(4):2424-7. PubMed ID: 15687325
[TBL] [Abstract][Full Text] [Related]
54. Anti-fibroblast growth factor 23 antibody therapy.
Fukumoto S
Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):346-51. PubMed ID: 24848934
[TBL] [Abstract][Full Text] [Related]
55. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
[TBL] [Abstract][Full Text] [Related]
56. [FGF-23 on hypophosphatemic rickets/osteomalacia].
Imanishi Y
Clin Calcium; 2002 May; 12(5):634-7. PubMed ID: 15775350
[TBL] [Abstract][Full Text] [Related]
57. Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells.
Yan X; Yokote H; Jing X; Yao L; Sawada T; Zhang Y; Liang S; Sakaguchi K
Genes Cells; 2005 May; 10(5):489-502. PubMed ID: 15836777
[TBL] [Abstract][Full Text] [Related]
58. Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis.
Bergwitz C; Banerjee S; Abu-Zahra H; Kaji H; Miyauchi A; Sugimoto T; Jüppner H
J Clin Endocrinol Metab; 2009 Nov; 94(11):4267-74. PubMed ID: 19837926
[TBL] [Abstract][Full Text] [Related]
59. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
Weber TJ; Liu S; Indridason OS; Quarles LD
J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
[TBL] [Abstract][Full Text] [Related]
60. Hypophosphatemic rickets.
Baroncelli GI; Toschi B; Bertelloni S
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):460-7. PubMed ID: 23108197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
